FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:773 September 5, 2002 Number 10

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Second edition. Edited by Suzanne Crowe, Jennifer Hoy, and John Mills. 630 pp., illustrated. London, Martin Dunitz, 2002. $190. ISBN 1-901865-28-2.

It is difficult to think of a topic in biomedicine about which it is harder to write a textbook than human immunodeficiency virus type 1 (HIV-1) and AIDS. The past two decades, and certainly the past five or six years, have seen remarkable changes in state-of-the-art diagnosis of and therapy for HIV-1 infection. Some advances in the field, such as highly active antiretroviral therapy (HAART), have been revolutionary. A textbook on this topic could be out of date before it even comes to print.

Lately, however, the field has matured. HIV-1 infection, at least in the developed world, has begun . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.